Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce
Date
2020-03-01Author
Swanepoel, Charles R.
McCulloch, Mignon I.
Abraham, Georgi
Donner, Jo-Ann
Alrukhaimi, Mona N.
Blake, Peter G.
Bunnag, Sakarn
Claus, Stefaan
Dreyer, Gavin
Ghnaimat, Mohammad A.
Ibhais, Fuad M.
Liew, Adrian
McKnight, Marla
Yewondwossen Tadesse, Mengistu
Naicker, Saraladevi
Niang, Abdou
Obrador, Gregorio T.
Perl, Jeffrey
Harun Ur, Rashid
Tonelli, Marcello
Tungsanga, Kriang
Vachharajani, Tushar
Zakharova, Elena
Zúñiga San Martín, Carlos Alberto
Finkelstein, Fredric O.
Publisher
ElsevierDescription
Artículo de publicación ISIMetadata
Show full item recordAbstract
Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease treatment. The nephrology workforce (nurses, technicians, and doctors) is limited in these countries and expanding the size and expertise of the workforce is essential to permit expansion of treatment for both chronic kidney disease and end-stage kidney disease. To achieve this will require sustained action and commitment from governments, academic medical centers, local nephrology societies, and the international nephrology community.